Amphastar Pharmaceuticals reported its third-quarter 2025 results, revealing quarterly revenues of US$191.84 million and net income of US$17.35 million, with sales of Baqsimi and Primatene Mist ...

Amphastar Pharmaceuticals' third quarter results for 2025 came in ahead of Wall Street's revenue and profit expectations, despite essentially flat sales compared to the prior year. The quarter was ...

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) achieved net revenues of $191.8 million for the third quarter, with a GAAP net income of $17.3 million. The company's core products, Bexsemi and Primatene ...

Contaminated herbal inhalers, like the recalled Hong Thai inhaler, pose risks of lung infections, especially for vulnerable groups like the elderly and those with lung disease. Ingredients such as ...

An over-the-counter asthma inhaler, Primatene Mist, was initially thought to have contributed to the death In the late '80s and early '90s, you couldn't crack a teen magazine without seeing pictures ...

The MarketWatch News Department was not involved in the creation of this content. -- Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience ...

Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the availability of many ...

(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...

Inhalers Produce More Than A Half-Million Cars' Worth of Carbon Emissions Annually By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 7, 2025 (HealthDay News) — Inhalers provide breath-saving relief ...